Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1990-06-25
1992-03-17
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
540498, A61K 4902, C07D48700
Patent
active
050966952
ABSTRACT:
Radioiodine 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine derivatives and their use as brain imaging agents.
REFERENCES:
patent: 4316839 (1982-02-01), Gerecke et al.
patent: 4352818 (1982-12-01), Hunkler
patent: 4777169 (1988-10-01), Earley
patent: 4885152 (1989-12-01), Nakatsuka et al.
Scholl, Journal of Nuclear Medicine, vol. 24, No. 5, May 1988.
Zech, International Journal of Radiation App. and Instrumentation, Part A, 39, (1988), No. 4.
Beer et al., European Nuclear Medicine Congress, Budapest, Hungary, Aug. 24-28, 1987.
Wu et al., Soc. Nucl. Medicine (USA), Washington, D.C., Jan. 22-25.
Hunkeler et al., Nature, vol. 290, Apr. 9, 1981, p. 514.
Maziere et al., Jol. Appl., Radiat. Isot., vol. 35, No. 10, p. 973, 1984.
Shinotoh et al., J. Nucl. Med., 27, No. 10, Oct. 1986.
Carmann Heinz
Hunkeler Walter
Epstein William H.
Gould George M.
Hoffmann-La-Roche Inc.
Maples John S.
LandOfFree
Radioiodine benzodiazepines as brain imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioiodine benzodiazepines as brain imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioiodine benzodiazepines as brain imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1474528